<Suppliers Price>

Diethyl 2-propylmalonate

Names

[ CAS No. ]:
2163-48-6

[ Name ]:
Diethyl 2-propylmalonate

[Synonym ]:
Diethyl 2-propylmalonate
EINECS 218-492-2
DIETHYL N-PROPYLMALONATE
Malonic acid, propyl-, diethyl ester
Propanedioic acid, propyl-, diethyl ester
Propylmalonic acid diethyl ester
MFCD00009168
Diethyl propylmalonate
Malonic acid,propyl-,diethyl ester
Propanedioic acid, 2-propyl-, diethyl ester

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
221.5±0.0 °C at 760 mmHg

[ Molecular Formula ]:
C10H18O4

[ Molecular Weight ]:
202.247

[ Flash Point ]:
91.7±0.0 °C

[ Exact Mass ]:
202.120514

[ PSA ]:
52.60000

[ LogP ]:
2.11

[ Vapour Pressure ]:
0.1±0.4 mmHg at 25°C

[ Index of Refraction ]:
1.430

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US)

[ Hazard Codes ]:
Xi

[ Safety Phrases ]:
S16-S24/25

[ WGK Germany ]:
3

[ HS Code ]:
2917190090

Customs

[ HS Code ]: 2917190090

[ Summary ]:
2917190090 acyclic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

Controlled Endolysosomal Release of Agents by pH-responsive Polymer Blend Particles.

Pharm. Res. 32 , 2280-91, (2015)

A key step of delivering extracellular agents to its intracellular target is to escape from endosomal/lysosomal compartments, while minimizing the release of digestive enzymes that may compromise cell...

Endosomolytic Nano-Polyplex Platform Technology for Cytosolic Peptide Delivery To Inhibit Pathological Vasoconstriction.

ACS Nano 9 , 5893-907, (2015)

A platform technology has been developed and tested for delivery of intracellular-acting peptides through electrostatically complexed nanoparticles, or nano-polyplexes, formulated from an anionic endo...

Rational design of composition and activity correlations for pH-responsive and glutathione-reactive polymer therapeutics.

J. Control. Release 104(2) , 417-27, (2005)

Limited cytoplasmic delivery of enzyme-susceptible drugs remains a significant challenge facing the development of protein and nucleic acid therapies that act in intracellular compartments. "Smart" pH...


More Articles


Related Compounds